• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; VELA SUPRARENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; VELA SUPRARENAL Back to Search Results
Model Number A28-28/C75-O20V
Medical Device Problem Codes Misconnection (1399); Material Puncture/Hole (1504); Product Quality Problem (1506); Material Integrity Problem (2978)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 03/06/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The explanted devices involved in this event have not be returned for evaluation.If additional information is obtained at a later time that is pertinent to this event, a follow-up report will then be submitted.Device iteration is afx with strata.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the afx abdominal aortic aneurysm stent.Approximately 4.5 years post initial procedure, a type iiia endoleak with component separation and non-intact fabric (type iiib endoleak) of the proximal extension were detected during routine exam by a cardiologist.The physician elected to treat the patient by explanting the afx devices on (b)(6) 2019, but it unknown if these devices are available for return.The patient has been discharged home with fatigue, but condition is improving.There have been no additional patient sequelae reported.
 
Additional Manufacturer Narrative
An evaluation of the reported event could not be completed due to a lack of receipt of relevant medical records and/or imaging.Several attempts were made to obtain medical records and images but the request for medical records was denied and no response was received for the request of medical images.As such, event determination, off label conditions, related patient harms and patient disposition could not be assessed.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The explanted device was not returned; therefore, no evaluation was completed.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Device iteration is afx with strata.Corrections: g1,2: contact office- name has been updated.H6: result code: remove code 3233.H6: conclusion code: remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Common Device Name
VELA SUPRARENAL
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key8735811
Report Number2031527-2019-00290
Device Sequence Number14096287
Product Code MIH
UDI-Device Identifier00818009013583
UDI-Public(01)00818009013583(17)150130
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 05/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/30/2015
Device Model NumberA28-28/C75-O20V
Device Lot Number1210036-023
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/31/2019
Supplement Date Received by Manufacturer05/31/2019
Initial Report FDA Received Date06/26/2019
Supplement Report FDA Received Date04/14/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0008-2019
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AFX BIFURCATED STENT GRAFT: 1046820-015; AFX BIFURCATED STENT GRAFT: 1046821-011; AFX BIFURCATED STENT GRAFT: 1046820-015; AFX BIFURCATED STENT GRAFT: 1046821-011
Outcome Attributed to Adverse Event Required Intervention;
Patient Age82 YR
-
-